Amer S. Pharaon is Executive Director, Deputy General Counsel, Patient Protection and Market Integrity at Novo Nordisk, bringing extensive legal expertise to the pharmaceutical sector. They previously served as Litigation Managing Assistant General Counsel at Novo Nordisk. Within the pharmaceutical legal environment at Novo Nordisk, Amer focused on patient protection and market integrity.
Prior to joining Novo Nordisk, Amer was Senior Corporate Counsel at Quest Diagnostics Inc, providing legal advisory services within the medical testing and clinical laboratories industry. Their work history includes serving as Senior Litigator at Squire Patton Boggs, demonstrating capabilities in dispute resolution and litigation strategies. Earlier in their career, Amer was an Associate at Latham & Watkins.
Their background reflects a strong focus on legal frameworks, supported by a Doctor of Law from the University of Michigan Law School and a Bachelor of Arts from Franklin & Marshall College. Amer also attended Northfield Mount Hermon.
